Abstract
Farnesyl-diphosphate farnesyltransferase 1 (FDFT1, squalene synthase), a membrane-associated enzyme, synthesizes squalene via condensation of two molecules of farnesyl pyrophosphate. Accumulating evidence has noted that FDFT1 plays a critical role in cancer, particularly in metabolic reprogramming, cell proliferation, and invasion. Based on these advances in our knowledge, FDFT1 could be a potential target for cancer treatment. This review focuses on the contribution of FDFT1 to the hallmarks of cancer, and further, we discuss the applicability of FDFT1 as a cancer prognostic marker and target for anticancer therapy.
| Original language | English |
|---|---|
| Article number | 2352 |
| Pages (from-to) | 1-33 |
| Number of pages | 33 |
| Journal | Cells |
| Volume | 9 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cholesterol synthesis
- Farnesyl-diphosphate farnesyltransferase 1
- Lipid rafts
- Prognostic marker
- Tumour progression
Fingerprint
Dive into the research topics of 'Roles of farnesyl-diphosphate farnesyltransferase 1 in tumour and tumour microenvironments'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver